Dr. Solly Silwan Chedid, MD

Dr. Chedid practices at Singing River Gulfport Ambulatory in Gautier, Mississippi.

Dr. Chedid's NPI, 1972586188, was assigned on November 22, 2005. Dr. Chedid graduated from Joe R. & Teresa Lozano Long School of Medicine in 1999. Dr. Chedid holds Mississippi license 29039.

Dr. Chedid's primary practice is Singing River Gulfport Ambulatory, at 2101 Hwy 90, Gautier, MS 39553 in Jackson County. The practice phone is (228) 575-7975.

Dr. Chedid's primary practice is Singing River Gulfport Ambulatory in Gautier, Mississippi. Dr. Chedid is also affiliated with Pascagoula Hospital. The medical group on file is Singing River Health System. Dmand AI also links Dr. Chedid to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chedid practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Chedid's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Chedid is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Chedid's licenses on file in 7 states: Mississippi, New Hampshire, Colorado, Texas, Florida, Massachusetts and New Jersey.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, multiple myeloma, neutropenia and purpura and thrombocytopenia among the conditions Dr. Chedid treats.

CMS data shows 1,151 Medicare services from Dr. Chedid across 7 procedure codes in 2024, for 207 Medicare patients. Medicare paid $95,499 for them.

CMS counts 207 Medicare patients who saw Dr. Chedid in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chedid's median patient age at 69, with 57% women.

In 2024, Dr. Chedid wrote 1,651 Medicare Part D claims for 212 patients. 85% of them were for generic drugs. CMS names the drug for 1,358 of them, across 38 drugs with 11 or more claims each, at $1,509,498 in total drug cost. In 2023, CMS named 1,247 claims across 27 drugs.

Dr. Chedid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chedid as offering telehealth.

Dmand AI links 1 paper to Dr. Chedid in 2024.

Dmand AI links Dr. Chedid to 3 clinical trials. Conditions studied include Carcinoma, Renal Cell, Rectal Neoplasms and Kidney Neoplasms. Open Payments lists research payments to Dr. Chedid that name 1 trial.

CMS Open Payments shows 2,855 general payments to Dr. Chedid from 84 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $436,260. It also lists 2 research payments totaling $7,080 in 2016, naming 1 clinical trial.

Dr. Chedid graduated from Joe R. & Teresa Lozano Long School of Medicine in 1999. Dr. Chedid is a member of ASCO and ASH.

Dr. Chedid is in network with 19 carriers, including Elevance, United Healthcare and Aetna. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.